Tustin, Calif.-based Canon Medical announces that its Clear-IQ Engine (AiCE) Deep Learning Reconstruction can now be used for 96% of all procedures using the Vantage Orian 1.5T MR system, expanding from previously FDA-cleared brain and knee indications to a vastly larger number of clinical indications, from prostate to shoulders, including all joints, cardiac, pelvis, abdomen and spine.
Canon officials say AiCE was trained using vast amounts of image data and features a deep learning neural network that can reduce noise and boost signal to deliver clear images, allowing clinicians to boost image quality, performance, productivity, and throughput.
“As we continue to expand the availability of AiCE, Canon Medical is ensuring that the maximum number of patients can benefit from the advanced images, expanded clinical capabilities and seamless integration that this advanced AI technology provides,” says Jonathan Furuyama, managing director, MR Business Unit, Canon Medical Systems USA, Inc. “In today’s environment, making images easy to read and acquire is more important than ever, and this is the latest demonstration of our commitment to offering accessible AI that clinicians can use to make the greatest impact on patient care.”
With the expansion of indications, Canon Medical’s AiCE Challenge has also expanded.
Featured image: The Vantage Orian 1.5T MR system
